Description
RADIOPHARMACEUTICAL
First action · last action
2026-03-12 · 2026-03-12
Transactions
1
First transaction's obligation
$24,000
Base + all options value (sum of deltas)
$24,000
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION (FAR 13)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2026-03-12+$24,000= $24,000
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2026-03-12 | +$24,000 | $24,000 | RADIOPHARMACEUTICAL |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CWN9UGL3NCL9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226N0711 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $100,008 | FY2026 |
| 36C24126P0328 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $999,797 | FY2026 |
| 36C25726N0407 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $1,400,000 | FY2026 |
| 36C25526N0361 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $228,679 | FY2026 |
| 36C24426N0938 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $650,641 | FY2026 |
| 36C24426D0097 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under Q517 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24726P0615 | PHARMALINK INC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $20,400 | FY2026 |
| 36C24726F0046 | MINBURN TECHNOLOGY GROUP, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $147,618 | FY2026 |
| 36C24726F0260 | NOVARTIS PHARMACEUTICALS CORPORATION | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $0 | FY2026 |
| 36C24725P0955 | ICP HOLDINGS, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $38,000 | FY2025 |
| 36C24725P0244 | PALISADE STRATEGIES, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $124,567 | FY2025 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24726P0429_3600_-NONE-_-NONE- · retrieved 2026-09-26.